The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(4-Hydroxyphenyl)-3-(4-(4-(trifluoromethyl)phenyl)piperazin-1-yl)propan-1-one ID: ALA4475359
PubChem CID: 155537441
Max Phase: Preclinical
Molecular Formula: C20H21F3N2O2
Molecular Weight: 378.39
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=C(CCN1CCN(c2ccc(C(F)(F)F)cc2)CC1)c1ccc(O)cc1
Standard InChI: InChI=1S/C20H21F3N2O2/c21-20(22,23)16-3-5-17(6-4-16)25-13-11-24(12-14-25)10-9-19(27)15-1-7-18(26)8-2-15/h1-8,26H,9-14H2
Standard InChI Key: OIARJOLWLNTRJC-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
16.5109 -18.7081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5097 -19.5355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2246 -19.9483 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9410 -19.5350 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9381 -18.7045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2227 -18.2954 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6511 -18.2893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3670 -18.6991 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6479 -17.4643 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.0800 -18.2839 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7959 -18.6938 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.7949 -19.9474 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.7967 -19.5172 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5087 -19.9269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2239 -19.5152 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.2228 -18.6893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5064 -18.2750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9359 -19.9248 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9345 -20.7509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6481 -21.1633 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3636 -20.7508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3609 -19.9215 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6467 -19.5128 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0806 -21.1587 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7313 -21.5332 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
25.1301 -22.0096 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
25.8862 -20.8513 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 1 0
7 9 2 0
8 10 1 0
10 11 1 0
2 12 1 0
11 13 1 0
11 17 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
15 18 1 0
24 25 1 0
24 26 1 0
24 27 1 0
21 24 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 378.39Molecular Weight (Monoisotopic): 378.1555AlogP: 3.81#Rotatable Bonds: 5Polar Surface Area: 43.78Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 7.89CX Basic pKa: 7.14CX LogP: 3.48CX LogD: 3.59Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.80Np Likeness Score: -1.18
References 1. Paucar R, Martín-Escolano R, Moreno-Viguri E, Azqueta A, Cirauqui N, Marín C, Sánchez-Moreno M, Pérez-Silanes S.. (2019) Rational modification of Mannich base-type derivatives as novel antichagasic compounds: Synthesis, in vitro and in vivo evaluation., 27 (17): [PMID:31345745 ] [10.1016/j.bmc.2019.07.029 ]